• Explore /
  • Poster
  • / First-line (1L) immuno-oncology (IO) combination therapies in metastatic renal cell carcinoma (mRCC): Preliminary results from the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC).

First-line (1L) immuno-oncology (IO) combination therapies in metastatic renal cell carcinoma (mRCC): Preliminary results from the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC).

Abstract Poster

Authors

null

Shaan Dudani

Tom Baker Cancer Centre, University of Calgary, Calgary, AB, Canada

Shaan Dudani , Jeffrey Graham , Connor Wells , Sumanta K. Pal , Nazli Dizman , Frede Donskov , Georg A. Bjarnason , Aaron Richard Hansen , Marco Adelmo James Iafolla , Ulka N. Vaishampayan , Camillo Porta , Benoit Beuselinck , Flora Yan , Lori Wood , Elizabeth Chien Hern Liow , Christian K. Kollmannsberger , Takeshi Yuasa , Chiyuan A Zhang , Toni K. Choueiri , Daniel Yick Chin Heng

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session C: Renal Cell Cancer

Track

Renal Cell Cancer

Sub Track

Renal Cell Cancer

Citation

J Clin Oncol 37, 2019 (suppl 7S; abstr 584)

DOI

10.1200/JCO.2019.37.7_suppl.584

Abstract #

584

Poster Bd #

F1

Abstract Disclosures

Similar Posters

First Author: Shaan Dudani

First Author: Igor Stukalin

Poster

2024 ASCO Genitourinary Cancers Symposium

Erectile function in patients with metastatic renal cell carcinoma treated with first-line therapy.

Erectile function in patients with metastatic renal cell carcinoma treated with first-line therapy.

First Author: Ilya Tsimafeyeu

First Author: Audreylie Lemelin